Read + Share
Meirson T, Goldstein DA, Gyawali B, Tannock IF, et al. Review of the monarchE trial suggests no evidence to support use of adjuvant
abemaciclib in women with breast cancer. Lancet Oncol 2023 May 2:S1470-2045(23)00165.
PMID: 37146621
|
 |
|
Meirson T, Goldstein DA, Gyawali B, Tannock IF, et al. Review of the monarchE trial suggests no evidence to support use of adjuvant
abemaciclib in women with breast cancer. Lancet Oncol 2023 May 2:S1470-2045(23)00165.
PMID: 37146621
|
|
|
|